Medicamen Biotech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

522.60

-27.35 (-4.97%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

522.60

-27.35 (-4.97%)
16:02 Dec 20

Quality

28/100
Low Financial Strength

Valuation

22/100
Expensive Valuation

Technical

56/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	112.72	115.45	140.87	179.31	181.61
Operating Expenses +	93.5	91.9	116.99	157.07	162.22
Raw Material	68.42	55.69	81.8	109.54	101.53
Increase Decrease in Cost	1.04	-3.34	-9.71	-16.94	-4.41
Other Manufacturing Expense	9.74	15.1	13.9	9.41	0
Employee Cost	9	14.5	20.44	30.07	31.87
Miscellaneous Expenses	5.3	9.95	10.56	34.67	33.23
Operating Profit	19.22	23.55	23.88	22.24	19.39
Other Income	0.75	1.72	2.46	2.33	2.28
Depreciation	2.52	5.77	6.37	7.09	7.95
Interest	1.06	1.4	2.92	4.4	4.29
Profit before tax and exceptio..	16.39	18.09	17.04	13.08	9.43
Exceptional Items	0	0	0	0	0
PBT	16.39	18.09	17.04	13.08	9.43
Provision for Taxation	4.26	3.2	2.32	3.58	3.67
Net Profit	12.13	14.9	14.73	9.49	5.77
NET Profit after MI	12.13	14.9	14.84	10.93	6.97
EPS	9.93	12.19	11.92	7.5	4.55
Operating Profit Margin (%)	17.05	20.4	16.95	12.4	10.68
Net Profit Margin (%)	10.76	12.91	10.53	6.1	3.84

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	43.00	43.00	43.20	43.20	43.20
FII	0.10	0.10	0.10	0.20	0.20
MF	0.00	0.00	0.00	0.00	0.00
Public	55.80	55.80	55.70	55.90	56.40
Others	0.00	0.00	0.00	0.00	0.00
Others	1.10	1.10	1.00	0.70	0.20